Liam Thompson tested the world's most annoying bed to explore sleep challenges. Senate to vote Friday on pathway to end shutdown Chris Hemsworth, Alzheimer's and why Hollywood is suddenly obsessed ...

Whether you root for the Dodgers or the Blue Jays, these hotels and restaurants near the action hit all the right marks. BySpencer Whaley, Contributor. Forbes contributors publish independent expert ...

Security expert Troy Hunt just added a huge new dataset to the Have I Been Pwned database containing 183 million new email accounts with leaked login details. It was collected with the help of ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Credit: Eight Sleep Pod ...

James is a published author with multiple pop-history and science books to his name. He specializes in history, space, strange science, and anything out of the ordinary.View full profile James is a ...

New World Development Co. will issue up to $1.9 billion of new debt in an exchange offer for some of its outstanding notes that includes as much as a 50% haircut for perpetual bond holders. The ...

CEDAR RAPIDS, Iowa (KCRG) - Children of all ages are spending more hours than ever in front of screens — and for many teens, that number keeps climbing. According to the CDC, about half of teenagers ...

One of the world’s poorest countries is reeling from the impact of US President Donald Trump’s tariff regime, which has crippled its key textile industry and exacerbated already high unemployment.

Get any of our free daily email newsletters — news headlines, opinion, e-edition, obituaries and more. NYON, Switzerland (AP) — Spain and England will renew their great rivalry in women’s soccer in a ...

PARIS (AP) — Charles Coste, the world’s oldest living Olympian and a cycling champion, has died. He was 101. The French presidency said in a statement on Tuesday that Coste died last Thursday. Coste ...

SINGAPORE & OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) will present data from two global Phase 3 double-blind, placebo-controlled studies of oveporexton (TAK-861) 1, ...